Company: ISRG
Filing Date: 2025-07-23
Form Type: 10-Q
Source: 0001035267-25-000192
Chunk: 137

Company: INTUITIVE SURGICAL INC
Filing Date: 2025-07-23
Form: 10-Q
Item: Item 1A
Chunk 137
---
 policies regarding transactions in the Company’s securities.On May 21, 2025, Fredrik C. Widman, the Company’s Corporate Controller and Principal Accounting Officer, adopted a Rule 10b5-1 trading plan. Mr. Widman’s trading plan provides for the potential sale of up to 8,714 shares of the Company’s common stock, including the potential exercise and sale of up to 7,284 shares of the Company’s common stock subject to stock options, until May 21, 2026. This trading plan was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and the Company’s policies regarding transactions in the Company’s securities.On May 30, 2025, Henry H. Charlton, the Company’s Chief Commercial and Marketing Officer, adopted a Rule 10b5-1 trading plan. Mr. Charlton’s trading plan provides for the potential sale of up to 22,731 shares of the Company’s common stock, including the potential exercise and sale of up to 18,000 shares of the Company’s common stock subject to stock options, until June 1, 2026. This trading plan was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and the Company’s policies regarding transactions in the Company’s securities.On June 4, 2025, Amy L. Ladd, M.D., a member of the Company’s Board of Directors, adopted a Rule 10b5-1 trading plan. Dr. Ladd’s trading plan provides for the potential sale of up to 671 shares of the Company’s common stock until June 4, 2026. This trading plan was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and the Company’s policies regarding transactions in the Company’s securities.On June 11, 2025, David J. Rosa, who was then the Company’s President and a member of the Company’s Board of Directors and who now serves as the Company’s Chief Executive Officer and a member of the Company’s Board of Directors, adopted a Rule 10b5-1 trading plan. Mr. Rosa’s trading plan provides for the potential exercise and sale of up to 27,000 shares of the Company’s common stock subject to stock options until